ArticleFrontiers in immunology2023

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells.

Vinicio Melo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.